MDS and AML Prior to Allogeneic SCT
2 clinical trials · Condition
◉ Watch MDS and AML Prior to Allogeneic SCT
| Record | Firm | Date |
|---|---|---|
| Proton-Based Total Marrow Irradiation for Allogeneic Transplantation in High-Risk AML/MDS (NCT07532824) | Institute of Hematology and Blood Transfusion, Czech Republic | 2025-11-21 |
| Assessment of Body, Liver and Labile Plasma Iron and Their Association With Outcome and Immunological Recovery in Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML) Patients Undergoing Allogeneic Stem Cell Transplantation - ALLIVE (ALLogeneic Iron inVEstigators) Observational Trial (NCT01746147) | GWT-TUD GmbH | 2012-12-01 |
Track MDS and AML Prior to Allogeneic SCT automatically
Every clearance here is in the API, with alerts when new ones post.